Hokyung Kay Chung

Hokyung Kay Chung

Auto-generated profile, based on publicly available information

Hokyung Kay Chung

University of North Carolina at Chapel Hill 8 Department of Cell Biology and Physiology Chapel Hill, NC

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2012 in Science
Verified
Journal Article
Closed access
PDF file
XZXin X. Zhou
Xin X. Zhou
HCHokyung K. Chung
Hokyung K. Chung
ALAmy J. Lam
Amy J. Lam
Michael LinMichael Lin
Michael Lin
Optogenetic Control: Fluorescent proteins are widely used as optical sensors; however, optical control of protein activity remains challenging. Zhou et al. (p. 810 ) describe an approach that allows both sensing and control. Domains of the fluorescent protein Dronpa were designed to dimerize with one another and were fused to each of the termini of an enzyme domain. In the dark, the domains dimerized and inhibited the enzyme. However, exposure to light induced Dronpa dissociation and activated the enzyme, allowing optogenetic control.

27 July 2015 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
HCHokyung K Chung
Hokyung K Chung
CJConor L Jacobs
Conor L Jacobs
YHYunwen Huo
Yunwen Huo
JYJin Yang
Jin Yang
SKStefanie A Krumm
Stefanie A Krumm
Michael LinMichael Lin
Michael Lin
SMASh is a strategy for regulating protein stability, in which treatment with a small molecule targets a protein tagged with a self-removing degron that includes an HCV protease sequence. SMASh was used to target measles virus phosphoprotein P, for which no inhibitors exist. An effective method for direct chemical control over the production of specific proteins would be widely useful. We describe small molecule–assisted shutoff (SMASh), a technique in which proteins are fused to a degron that removes itself in the absence of drug, resulting in the production of an untagged protein. Clinically tested HCV protease inhibitors can then block degron removal, inducing rapid degradation of subsequently synthesized copies of the protein. SMASh allows reversible and dose-dependent shutoff of various proteins in multiple mammalian cell types and in yeast. We also used SMASh to confer drug responsiveness onto an RNA virus for which no licensed inhibitors exist. As SMASh does not require the permanent fusion of a large domain, it should be useful when control over protein production with minimal structural modification is desired. Furthermore, as SMASh involves only a single genetic modification and does not rely on modulating protein-protein interactions, it should be easy to generalize to multiple biological contexts.

10 January 2025 in Science
Verified
Journal Article
Closed access
SVSiva Karthik Varanasi
Siva Karthik Varanasi
DCDan Chen
Dan Chen
YLYingluo Liu
Yingluo Liu
MJMelissa A. Johnson
Melissa A. Johnson
CMCayla M. Miller
Cayla M. Miller
SKSusan M. Kaech
Susan M. Kaech
The metabolic landscape of cancer greatly influences antitumor immunity, yet it remains unclear how organ-specific metabolites in the tumor microenvironment influence immunosurveillance. We found that accumulation of primary conjugated and secondary bile acids (BAs) are metabolic features of human hepatocellular carcinoma and experimental liver cancer models. Inhibiting conjugated BA synthesis in hepatocytes through deletion of the BA-conjugating enzyme bile acid–CoA:amino acid N -acyltransferase (BAAT) enhanced tumor-specific T cell responses, reduced tumor growth, and sensitized tumors to anti–programmed cell death protein 1 (anti–PD-1) immunotherapy. Furthermore, different BAs regulated CD8 + T cells differently; primary BAs induced oxidative stress, whereas the secondary BA lithocholic acid inhibited T cell function through endoplasmic reticulum stress, which was countered by ursodeoxycholic acid. We demonstrate that modifying BA synthesis or dietary intake of ursodeoxycholic acid could improve tumor immunotherapy in liver cancer model systems.

7 February 2025 in Science
Verified
Journal Article
Closed access
SMShixin Ma
Shixin Ma
MDMichael S. Dahabieh
Michael S. Dahabieh
TMThomas H. Mann
Thomas H. Mann
SZSteven Zhao
Steven Zhao
BMBryan McDonald
Bryan McDonald
SKSusan M. Kaech
Susan M. Kaech
Exhausted T cells (TEX) in cancer and chronic viral infections undergo metabolic and epigenetic remodeling, impairing their protective capabilities. However, the impact of nutrient metabolism on epigenetic modifications that control TEX differentiation remains unclear. We showed that TEX cells shifted from acetate to citrate metabolism by down-regulating acetyl-CoA synthetase 2 (ACSS2) while maintaining ATP-citrate lyase (ACLY) activity. This metabolic switch increased citrate-dependent histone acetylation, mediated by histone acetyltransferase KAT2A-ACLY interactions, at TEX signature genes while reducing acetate-dependent histone acetylation, dependent on p300-ACSS2 complexes, at effector and memory T cell genes. Nuclear ACSS2 overexpression or ACLY inhibition prevented TEX differentiation and enhanced tumor-specific T cell responses. These findings unveiled a nutrient-instructed histone code governing CD8 + T cell differentiation, with implications for metabolic- and epigenetic-based T cell therapies.

22 September 2017 in ACS Chemical Biology
Verified
Journal Article
Open access
XZXin X. Zhou
Xin X. Zhou
XZXinzhi Zou
Xinzhi Zou
HCHokyung K. Chung
Hokyung K. Chung
YGYuchen Gao
Yuchen Gao
YLYanxia Liu
Yanxia Liu
Michael LinMichael Lin
Michael Lin
Optical control of CRISPR-Cas9-derived proteins would be useful for restricting gene editing or transcriptional regulation to desired times and places. Optical control of Cas9 functions has been achieved with photouncageable unnatural amino acids or by using light-induced protein interactions to reconstitute Cas9-mediated functions from two polypeptides. However, these methods have only been applied to one Cas9 species and have not been used for optical control of different perturbations at two genes. Here, we use photodissociable dimeric fluorescent protein domains to engineer single-chain photoswitchable Cas9 (ps-Cas9) proteins in which the DNA-binding cleft is occluded at baseline and opened upon illumination. This design successfully controlled different species and functional variants of Cas9, mediated transcriptional activation more robustly than previous optogenetic methods, and enabled light-induced transcription of one gene and editing of another in the same cells. Thus, a single-chain photoswitchable architecture provides a general method to control a variety of Cas9-mediated functions.

23 March 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
HCH. Kay Chung
H. Kay Chung
BMBryan McDonald
Bryan McDonald
SKSusan M. Kaech
Susan M. Kaech
In response to infection, T cells adopt a range of differentiation states, creating numerous heterogeneous subsets that exhibit different phenotypes, functions, and migration patterns. This T cell heterogeneity is a universal feature of T cell immunity, needed to effectively control pathogens in a context-dependent manner and generate long-lived immunity to those pathogens. Here, we review new insights into differentiation state dynamics and population heterogeneity of CD8+ T cells in acute and chronic viral infections and cancer and highlight the parallels and distinctions between acute and chronic antigen stimulation settings. We focus on transcriptional and epigenetic networks that modulate the plasticity and terminal differentiation of antigen-specific CD8+ T cells and generate functionally diverse T cell subsets with different roles to combat infection and cancer.